Collateral benefits of fish oil therapy for rheumatoid arthritis

Journal of Rheumatology

Volumn 33, Issue 10, 2006, Pages 1931-1933

  Lau, Chak Sing ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

ARACHIDONIC ACID; BIOLOGICAL FACTOR; CHOLESTEROL; CYCLOOXYGENASE 2 INHIBITOR; DISEASE MODIFYING ANTIRHEUMATIC DRUG; FISH OIL; HIGH DENSITY LIPOPROTEIN; ICOSANOID; LEUKOTRIENE; NONSTEROID ANTIINFLAMMATORY AGENT; PROSTAGLANDIN; THROMBOXANE; TUMOR NECROSIS FACTOR ALPHA INHIBITOR;

ANTIINFLAMMATORY ACTIVITY; CARDIOVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; DIET SUPPLEMENTATION; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; DRUG USE; EDITORIAL; GASTROINTESTINAL SYMPTOM; HUMAN; INFECTION; LIPOPROTEIN BLOOD LEVEL; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; TUBERCULOSIS;

ANTI-INFLAMMATORY AGENTS; ARTHRITIS, RHEUMATOID; CARDIOVASCULAR DISEASES; DIETARY SUPPLEMENTS; DOCOSAHEXAENOIC ACIDS; EICOSAPENTAENOIC ACID; FISH OILS; HUMANS; RISK FACTORS;

EID: 33750003878     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (12)

1. Belch JJF. Eicosanoids and rheumatology: Inflammatory and vascular aspects. Prostaglandins Leukot Essent Fatty Acids 1989;36:219-34.
2. Kremer JM, Biguouette J, Michalek AU. Effects of manipulating dietary fatty acids on clinical manifestations of rheumatoid arthritis. Lancet 1985;1:184-7.
3. Sperling RI, Weinblatt M, Robin JL, et al. Effects of dietary supplementation with marine fish oil on leukocyte lipid mediator generation and function in rheumatoid arthritis. Arthritis Rheum 1987;30:988-97.
4. Cleland LF, French JK, Betts WH, Murphy GA, Elliott MJ. Clinical and biochemical effects of dietary fish oil supplements in rheumatoid arthritis. J Rheumatol 1988;15:1471-5.
5. Belch JJF, Ansell D, Madhok R, Dowd AO, Sturrock RD. Effects of altering dietary essential fatty acids on requirements for non-steroidal anti-inflammatory drugs in patients with rheumatoid arthritis: a double blind placebo controlled study. Ann Rheum Dis 1988;47:96-104.
6. Lau CS, Morley KD, Belch JJ. Effects of fish oil supplementation on non-steroidal anti-inflammatory drug requirement in patients with mild rheumatoid arthritis - a double-blind placebo controlled study. Br J Rheumatol 1993;32:982-9.
7. Lichenstein D, Syngal S, Wolfe MM. Non-steroidal anti-inflammatory drugs and the gastrointestinal tract: the double-edged sword. Arthritis Rheum 1995;38:5-18.
8. Solomon DH. Selective cyclo-oxygenase 2 inhibitors and cardiovascular events. Arthritis Rheum 2005;52:1968-78.
9. Hippisley-Cox J, Coupland C. Risk of myocardial infarction in patients taking cyclo-oxygenase-2 inhibitors or conventional non-steroidal anti-inflammatory drugs: population based nested case-control analysis. BMJ 2005;330:1366.
10. Maradit-Kremers H, Nicola PJ, Crowson CS, Ballman KV, Gabriel SE. Cardiovascular death in rheumatoid arthritis: a population-based study. Arthritis Rheum 2005;52:722-32.
11. Cleland LG, Caughey GE, James MJ, Proudman SM. Reduction of cardiovascular risk factors with longterm fish oil treatment in early rheumatoid arthritis. J Rheumatol 2006;33:1973-9.
12. GISSI Prevenzione Investigators. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: Results of the GISSI Prevenzione trial. Lancet 1999;354:447-55.